GSK took advantage of ASCO dip to get discount on Nuvalent

June 12, 2026 07:14 AM EDT DealsPharma GSK took ad­van­tage of AS­CO dip to get dis­count on Nu­va­lent Max Gelman Senior Editor GSK’s $10.6 bil­lion buy­out of Nu­va­lent, an­nounced Tues­day, was the largest in the com­pa­ny’s his­to­ry. But did new CEO Luke Miels get … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER